$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[국내논문] 한의 종양학 연구 분야에서의 Propensity Score Matching Method 적용에 대한 문헌 고찰
A Literature Review on the Application of the Propensity Score Matching Method in the Field of Asian Oncology 원문보기

大韓癌韓醫學會誌 = Journal of Korean traditional oncology, v.27 no.1, 2022년, pp.25 - 36  

김동현 (대전대학교 한방내과학교실) ,  김종희 (대전대학교 한방내과학교실) ,  유화승 (대전대학교 서울한방병원 동서암센터) ,  박소정 (부산대학교 한의학전문대학원, 부산대학교 한방병원)

Abstract ▼ AI-Helper 아이콘AI-Helper

The Randomized Control Trial (RCT) is the most well-established and widely used statistical methodology in clinical research; however, applying thorough RCT to cancer patients presents challenges such as ethical concerns, high costs, short clinical periods, and limitations in collecting various side...

주제어

#Propensity Score Matching(PSM)   #Korean Medicine   #Traditional Chinese Medicine   #Oncology   #Cancer   #Carcinoma  

표/그림 (3)

참고문헌 (39)

  1. Dong Kyu Lee, An introduction to propensity score matching methods. Anesth Pain Med 2016; 11:130-148.？ 

    상세보기 crossref

  2. Luellen JK, Shadish WR, Clark MH. Propensity scores: an introduction and experimental test. Eval Rev 2005; 29: 530-58.？ 

    상세보기 crossref

  3. Hooker, Andrew C., Mats O. Karlsson, Justin J. Wilkins, and E. Niclas Jonsson. 2020. Xpose4: Diagnostics for Nonlinear Mixed-Effect Models.？ 

  4. Day AG. Why the propensity for propensity scores? Crit Care Med 2015; 43:2024-6.？ 

    상세보기 crossref

  5. Tusty ten Bensel, Benjamin Gibbs & Robert Lytle. A Propensity Score Approach towards Assessing Neighborhood Risk of Parole Revocation. American Journal of Criminal Justice volume 40, pages377-398 (2015).？ 

    상세보기 crossref

  6. Caliendo M, Kopeinig S. Some practical guidance for the implementation of propensity score matching. J Econ Surv 2008; 22:31-72.？ 

    상세보기 crossref

  7. 백영민, 박인서, 「R기반 성향점수분석: 루빈 인과모혈 기반 인과추론」, 한나래 아카데미, 2021？ 

  8. Dong Kyu Lee, An introduction to propensity score matching methods. Anesth Pain Med 2016; 11:130-148.？ 

    상세보기 crossref

  9. Shi, Qi, et al. "Exploring the medication duration based on the effect of traditional Chinese medicine on postoperative stage I-III colorectal patients: a retrospective cohort study." Oncotarget 8.8 (2017): 13488.？ 

    상세보기

  10. Chiu, Sheng-Chun, et al. "Potential therapeutic effects of N-butylidenephthalide from Radix Angelica Sinensis (Danggui) in human bladder cancer cells." BMC complementary and alternative medicine 17.1 (2017): 1-12.？ 

    상세보기 crossref

  11. Tsai, Yueh-Ting, et al. "Prescription of Chinese herbal products is associated with a decreased risk of invasive breast cancer." Medicine 96.35 (2017).？ 

  12. Ren, Xuejiao, et al. "Retrospective analysis of safety profile of high-dose concurrent chemoradiotherapy for patients with oesophageal squamous cell carcinoma." Radiotherapy and Oncology 129.2 (2018): 293-299.？ 

    상세보기 crossref

  13. Chen, Chin-Nu, Yueh-Ting Tsai, and Jung-Nien Lai. "8 years post-marketing surveillance between Asari Radix and hepatocellular carcinoma: Nationwide population-based evidence against an association." Journal of ethnopharmacology 243 (2019): 112094.？ 

    상세보기

  14. Xie, Gang, et al. "Aidi injection, a traditional Chinese medicine injection, could be used as an adjuvant drug to improve quality of life of cancer patients receiving chemotherapy: a propensity score matching analysis." Integrative cancer therapies 18 (2019): 1534735418810799.？ 

    상세보기

  15. Liu, Chien-Ting, et al. "Chemotherapy in conjunction with traditional Chinese medicine for survival of patients with early female breast cancer: protocol for a non-randomized, single center prospective cohort study." Trials 20.1 (2019): 1-8.？ 

    상세보기 crossref

  16. Chang, Chia-Chen, et al. "Conventional Western treatment associated with Chinese herbal medicine ameliorates the incidence of head and neck cancer among patients with esophageal cancer." Integrative cancer therapies 18 (2019): 1534735419834353.？ 

    상세보기

  17. Liu, Yao, et al. "Fufang Banmao Capsule, a Traditional Chinese Medicinal Formulation, Enhances the Survival of Patients with Hepatocellular Carcinoma and Vp3-4 Portal Vein Tumor Thrombosis Undergoing Supportive Treatment." The Journal of Alternative and Complementary Medicine 26.10 (2020): 956-965.？ 

    상세보기 crossref

  18. Lin, Tsai-Hui, et al. "Conventional western treatment combined with Chinese herbal medicine alleviates the progressive risk of lung cancer in patients with chronic obstructive pulmonary disease: A nationwide retrospective cohort study." Frontiers in pharmacology 10 (2019): 987.？ 

  19. Chen, Hsing-Yu, et al. "Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study." BMC complementary and alternative medicine 19.1 (2019): 1-13.？ 

    상세보기 crossref

  20. Su-Tong, Liu, et al. "The effect of long-term traditional Chinese medicine treatment on disease-free survival of postoperative stage I-III lung cancer patients: a retrospective cohort study." Traditional Medicine Research 4.2 (2019): 91.？ 

  21. Shi, Ke, et al. "Adjuvant Fuzheng Huayu capsule reduces the incidence of hepatocellular carcinoma in patients with hepatitis B-caused cirrhosis." Evidence-Based Complementary and Alternative Medicine 2020 (2020).？ 

    상세보기

  22. Huang, Chia-Yu, et al. "Chinese herbal medicine is helpful for survival improvement in patients with multiple myeloma in Taiwan: A nationwide retrospective matched-cohort study." Integrative Cancer Therapies 19 (2020): 1534735420943280.？ 

    상세보기

  23. Zhao, He-tong, et al. "Comparable effects of Jiedu Granule, a compound Chinese herbal medicine, and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort study." Journal of Integrative Medicine 18.4 (2020): 319-325.？ 

    상세보기 crossref

  24. Zhang, Zhen, et al. "Data Mining and System Pharmacology to Elucidate the Efficiency and Mechanism of Chinese Medicine in Treating Primary Liver Cancer." (2020).？ 

  25. Liao, Yu-Pei, et al. "Effects and relative factors of adjunctive Chinese medicine therapy on survival of hepatocellular carcinoma patients: a retrospective cohort study in taiwan." Integrative Cancer Therapies 19 (2020): 1534735420915275.？ 

    상세보기

  26. Wang, Yuli, et al. "The effect of long-term traditional Chinese medicine treatment on survival time of colorectal cancer based on propensity score matching: a retrospective cohort study." Evidence-Based Complementary and Alternative Medicine 2020 (2020).？ 

    상세보기

  27. Shi, Qi, et al. "A Four Ingredients Chinese Herbal Formula, Decreases the Metastatic Recurrence of Postoperative Patients With Stage II-III Colorectal Cancer." (2021).？ 

  28. Hou, Chao, et al. "Effect of Fuzheng Qingdu Therapy for Metastatic Gastric Cancer is Associated With Improved Survival: A Multicenter Propensity-Matched Study." Integrative cancer therapies 20 (2021): 15347354211058464.？ 

    상세보기

  29. Xu, Li-Li, et al. "The Efficacy of Long-Term Chinese Herbal Medicine Use on Lung Cancer Survival Time: A Retrospective Two-Center Cohort Study with Propensity Score Matching." Evidence-Based Complementary and Alternative Medicine 2021 (2021).？ 

    상세보기

  30. Shih, Wei-Tai, et al. "Traditional Chinese medicine enhances survival in patients with gastric cancer after surgery and adjuvant chemotherapy in Taiwan: a nationwide matched cohort study." Evidence-Based Complementary and Alternative Medicine (2021).？ 

  31. Yang, Shu-Yi, et al. "Association of Chinese herbal medicine use with the depression risk among the long-term breast cancer survivors: A longitudinal follow-up study." Frontiers in Psychology (2022).？ 

  32. Tan, Ying, et al. "Chinese herbal medicine combined with oxaliplatin-based chemotherapy for advanced gastric cancer: A systematic review and meta-analysis of contributions of specific medicinal materials to tumor response." Frontiers in pharmacology 13 (2022).？ 

  33. Hou, Zong, et al. "Comprehensive fecal metabolomics and gut microbiota for the evaluation of the mechanism of Panax Ginseng in the treatment of Qi-deficiency liver cancer." Journal of Ethnopharmacology 292 (2022): 115222.？ 

    상세보기

  34. Hou, Jie, et al. "Effects of Traditional Chinese Medicine Adjuvant Therapy on the Survival of Patients with Primary Liver Cancer." Evidence-Based Complementary and Alternative Medicine 2022 (2022).？ 

    상세보기

  35. Luo, Shaoju, and Hao Hu. "Huaier granule prolongs overall survival after curative resection of hepatocarcinoma carcinoma: A propensity score analysis." Journal of Ethnopharmacology (2022): 115774.？ 

  36. Li, Honglin, et al. "Traditional Chinese Medicine Decoctions Improve Longevity Following Diagnosis with Stage IV Esophageal Squamous Cell Carcinoma: A Retrospective Analysis." International Journal of General Medicine 15 (2022): 1665.？ 

    상세보기

  37. Tusty ten Bensel, Benjamin Gibbs & Robert Lytle. A Propensity Score Approach towards Assessing Neighborhood Risk of Parole Revocation. American Journal of Criminal Justice volume 40, pages377-398 (2015).？ 

    상세보기 crossref

  38. King, Gary, and Richard Nielsen. "Why propensity scores should not be used for matching: Supplementary appendix." (2016).？ 

  39. 박봉기, et al. "국내에 보고된 한국 한의학의 암치료 임상연구에 대한 계통적 고찰." 대한한방내과학회지 29.4 (2008): 1061-1074. 

저자의 다른 논문 :

관련 콘텐츠

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로